Evidence map›Paper›PMID 32545307›Full record

ArticleBiomolecules2020

IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells.

Adrianna Moszyńska, James F Collawn, Rafal Bartoszewski

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Old drugs, new challenges: reassigning drugs for cancer therapies.Cellular & molecular biology letters · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Dual RNase activity of IRE1 as a target for anticancer therapies.Journal of cell communication and signaling · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Molecular Mechanism Underlying Role of the XBP1s in Cardiovascular Diseases.Journal of cardiovascular development and disease · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Adrianna MoszyńskaDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, 80210 Gdansk, Poland.
James F CollawnDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Rafal BartoszewskiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, 80210 Gdansk, Poland.ORCID 0000-0002-2864-6757
Gdańsk Medical University · PLUniversity of Alabama at Birmingham · US

Funding

Cystic Fibrosis Foundation ROWE15R0Narodowe Centrum Nauki 2015/18/E/NZ3/00687NIH HHS NIH P30 DK072482
6 · The paper itself

Abstract

While the role of hypoxia and the induction of the hypoxia inducible factors (HIFs) and the unfolded protein response (UPR) pathways in the cancer microenvironment are well characterized, their roles and relationship in normal human endothelium are less clear. Here, we examined the effects of IRE1 on HIF-1α protein levels during hypoxia in primary human umbilical vein endothelial cells (HUVECs). The results demonstrated that HIF-1α levels peaked at 6 h of hypoxia along with two of their target genes,

Indexed as

Cell HypoxiaCells, CulturedEndoribonucleasesEndothelial CellsGene Knockdown TechniquesHumansHuman Umbilical Vein Endothelial CellsHypoxia-Inducible Factor 1, alpha SubunitProtein Serine-Threonine KinasesRNA, Small InterferingSignal TransductionEndoribonucleasesERN1 protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitProtein Serine-Threonine KinasesRNA, Small InterferingERN1HIF1AhypoxiaRIDDXBP1

Identifiers

PMID32545307
PMCPMC7355874
OpenAlexW3034609286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.